Ignite Creation Date:
2024-05-06 @ 7:09 PM
Last Modification Date:
2024-10-26 @ 3:01 PM
Study NCT ID:
NCT05911087
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-06-20
First Post:
2023-06-18
Brief Title:
A Phase IIIII Study to Evaluate the Immunogenicity and Safety and Efficacy of SWIM816 Vaccines for SARS-CoV-2
Sponsor:
Stemirna Therapeutics
Organization:
Stemirna Therapeutics
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-06-20
Start Date Type:
ESTIMATED
Primary Completion Date:
2023-07-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-02-01
Completion Date Type:
ESTIMATED
First Submit Date:
2023-06-18
First Submit QC Date:
June 18 2023
Study First Post Date:
2023-06-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-06-18
Last Update Post Date:
2023-06-20
Last Update Post Date Type:
ACTUAL